Acurx Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Acurx Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q3 2024.
  • Acurx Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 16.4M shares, a 25.8% increase year-over-year.
  • Acurx Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 12.7M shares, a 17.2% increase from 2022.
  • Acurx Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 10.8M shares, a 26.7% increase from 2021.
  • Acurx Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.54M shares, a 37.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 16.4M +3.36M +25.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 15.8M +3.64M +29.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 15.5M +3.83M +32.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 12.7M +1.86M +17.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 13M +1.86M +16.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 12.2M +1.92M +18.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 11.6M +1.41M +13.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 10.8M +2.28M +26.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 11.1M +1.03M +10.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 10.3M +3.29M +47.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 10.2M +3.37M +49% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 8.54M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 10.1M +3.85M +61.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 6.97M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 6.87M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 6.27M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.